Pharmacotherapy Management of COPD Exacerbation
This HEDIS Measure
Assesses chronic obstructive pulmonary disease (COPD) exacerbations for adults 40 years and older who had appropriate medication therapy to manage an exacerbation. A COPD exacerbation is defined as an inpatient or ED visit with a primary discharge diagnosis of COPD.
COPD exacerbations or “flare-ups” make up a significant portion of the costs associated with COPD.1 Approximately 15 million adults in the United States have COPD, an irreversible disease that limits airflow to the lungs, however, symptoms can be controlled with appropriate medication.2,3 Appropriate prescribing of medication following exacerbation can prevent future flare-ups and drastically reduce the costs of COPD.
1. Pasquale, M.K., S.X. Sun, F. Song, H.J. Hartnett, and S.A. Stemkowski. “Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.” International Journal of COPD 7:757-64. doi: 10.2147/COPD.S36997.
2. National Heart, Lung, and Blood Institute. 2012. “Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases.”
3. Global Initiative for Chronic Obstructive Lung Disease. 2014. “Global Strategy for the Diagnosis, and Prevention of Chronic Obstructive Pulmonary Disease.”